STRS Ohio’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,900
| Closed | -$52.1K | – | 2027 |
|
|
2024
Q3 | $52.1K | Sell |
7,900
-8,200
| -51% | -$54K | ﹤0.01% | 1797 |
|
|
2024
Q2 | $121K | Sell |
16,100
-4,200
| -21% | -$31.5K | ﹤0.01% | 1670 |
|
|
2024
Q1 | $202K | Sell |
20,300
-25,700
| -56% | -$256K | ﹤0.01% | 1551 |
|
|
2023
Q4 | $453K | Hold |
46,000
| – | – | ﹤0.01% | 1322 |
|
|
2023
Q3 | $351K | Buy |
46,000
+23,600
| +105% | +$180K | ﹤0.01% | 1403 |
|
|
2023
Q2 | $167K | Buy |
22,400
+1,700
| +8% | +$12.7K | ﹤0.01% | 1631 |
|
|
2023
Q1 | $138K | Hold |
20,700
| – | – | ﹤0.01% | 1671 |
|
|
2022
Q4 | $159K | Hold |
20,700
| – | – | ﹤0.01% | 1638 |
|
|
2022
Q3 | $220K | Hold |
20,700
| – | – | ﹤0.01% | 1582 |
|
|
2022
Q2 | $168K | Buy |
20,700
+6,100
| +42% | +$49.5K | ﹤0.01% | 1653 |
|
|
2022
Q1 | $104K | Sell |
14,600
-8,000
| -35% | -$57K | ﹤0.01% | 1834 |
|
|
2021
Q4 | $387K | Buy |
22,600
+16,000
| +242% | +$274K | ﹤0.01% | 1554 |
|
|
2021
Q3 | $151K | Buy |
6,600
+1,700
| +35% | +$38.9K | ﹤0.01% | 1858 |
|
|
2021
Q2 | $178K | Buy |
+4,900
| New | +$178K | ﹤0.01% | 1848 |
|